|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_on1044987027 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
180721t20172017ne a obf 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d EBLCP
|d MERUC
|d OCLCQ
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9789062998838
|q (electronic bk.)
|
| 020 |
|
|
|a 9062998836
|q (electronic bk.)
|
| 020 |
|
|
|z 9789062992515
|
| 020 |
|
|
|z 906299251X
|
| 029 |
1 |
|
|a AU@
|b 000068480597
|
| 035 |
|
|
|a (OCoLC)1044987027
|
| 050 |
|
4 |
|a RE48.9
|
| 072 |
|
7 |
|a MED
|x 085000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 617.7
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Roberts, Harry W.,
|e author.
|
| 245 |
1 |
0 |
|a Current clinical evidence in ophthalmology /
|c Harry W. Roberts, Jesse Gale, Keith R. Martin ; section editors, Harminder Dua (Cornea) [and 4 others] ; with additional retinal section author Dr. Neil Avery and contributions from Dr. Neil Sharma.
|
| 264 |
|
1 |
|a Amsterdam, The Netherlands :
|b Kugler Publications,
|c [2017]
|
| 264 |
|
4 |
|c Ã2017
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, January 11, 2019).
|
| 505 |
0 |
|
|a Intro; Introduction; Preface; About the authors; List of Abbreviations; Anterior Segment; Herpetic Eye Disease Study -- 1 (HEDS -- 1); Herpetic Eye Disease Study -- 2 (HEDS -- 2); Endophthalmitis Vitrectomy Study (EVS); European Society for Cataract and RefractiveSurgeons (ESCRS Study); Collaborative Longitudinal Evaluation ofKeratoconus (CLEK); Corneal collagen cross-linking in progressivekeratoconus; Glaucoma; Ocular Hypertension Treatment Study (OHTS); European Glaucoma Prevention Study (EGPS); Early Manifest Glaucoma Trial (EMGT); United Kingdom Glaucoma Treatment Study(UKGTS).
|
| 505 |
8 |
|
|a Advanced Glaucoma Intervention Study (AGIS)Collaborative Initial Glaucoma Treatment Study (CIGTS); Collaborative Normal-Tension Glaucoma Study(CNTGS); Low-Tension Glaucoma Treatment Study (LoGTS); Glaucoma Laser Trial (GLT); 5-Fluorouracil Filtering Surgery Study (FFSS); Tube Versus Trabeculectomy (TVT) study; Ahmed Baerveldt Comparison (ABC) and AhmedVersus Baerveldt (AVB) Studies; Effectiveness in Angle-closure Glaucoma of LensExtraction (EAGLE) Study; Retina; Diabetic Control and Complication Trial (DCCT)and Epidemiology of Diabetes Interventions andComplications (EDIC) trial.
|
| 505 |
8 |
|
|a United Kingdom Prospective Diabetes Study (UKPDS)Diabetic Retinopathy Study (DRS); Early Treatment of Diabetic Retinopathy Study (ETDRS); DRCR.NET Protocol I -- Macular Laser Combinedwith Ranibizumab or Triamcinalone vs. MacularLaser Alone; DRCR.NET Protocol T -- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema; DRCR.NET Protocol S -- PanretinalPhotocoagulation vs. Intravitreal Ranibizumab forProliferative Diabetic Retinopathy; Fenofibrate Intervention and Event Lowering inDiabetes (FIELD); Diabetic Retinopathy Vitrectomy Study (DRVS).
|
| 505 |
8 |
|
|a Ranibizumab for Diabetic Macular Oedema (RISE & RIDE)Ranibizumab Monotherapy or Combined with Laserversus Laser Monotherapy for Diabetic MacularEdema (RESTORE); Intravitreal Aflibercept for Diabetic Macular Edema(DA VINCI); Intravitreal Aflibercept for Diabetic Macular Edema (VIVID & VISTA); Bevacizumab or Laser Therapy in the Managementof Diabetic Macular Edema (BOLT); Fluocinolone Acetonide Vitreous Inserts forDiabetic Macular Edema (FAME A & B); The Age-Related Eye Disease Study (AREDS I).
|
| 505 |
8 |
|
|a Lutein, Zeaxanthin and Omega-3 Fatty Acids forAge-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS-2)Ranibizumab vs. Verteporfin for PredominantlyClassic Choroidal Neovascularisation in Age-Related Macular Degeneration (ANCHOR); Ranibizumab for Minimally Classic or OccultNeovascular Age-Related Macular Degeneration (MARINA); Randomised, Double-Masked, Sham-ControlledTrial of Ranibizumab for Neovascular Age-relatedMacular Degeneration (PIER); Safety and Efficacy of a Flexible Dosing Regimen ofRanibizumab in Neovascular Age-Related MacularDegeneration (SUSTAIN).
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Ophthalmology
|v Handbooks, manuals, etc.
|
| 650 |
|
6 |
|a Ophtalmologie
|v Guides, manuels, etc.
|
| 650 |
|
7 |
|a MEDICAL
|x Surgery
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a Ophthalmology.
|2 fast
|0 (OCoLC)fst01046503
|
| 655 |
|
7 |
|a Handbooks and manuals.
|2 fast
|0 (OCoLC)fst01423877
|
| 700 |
1 |
|
|a Gale, Jesse,
|e author.
|
| 700 |
1 |
|
|a Martin, Keith R.,
|e author.
|
| 776 |
0 |
8 |
|i Print version:
|a Roberts, Harry W.
|t Current clinical evidence in ophthalmology.
|d Amsterdam : Kugler Publications, [2017]
|z 9789062992515
|z 906299251X
|w (OCoLC)992748442
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1848428
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL5450696
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1848428
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15597882
|
| 994 |
|
|
|a 92
|b IZTAP
|
